RB1-negative cancers are more sensitive to some DNA-damaging agents such as 5-Fluorouracil [23], doxorubicin [24], and ionizing radiation [25], although the detailed mechanism for the RB1-negative selective effect remains unresolved. Here, RB1 is linked to cancer.